docetaxel anhydrous has been researched along with Inflammatory Bowel Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimi, A; Kato, J; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sakai, T; Sasaki, A; Satoh, M; Takimoto, R; Tateno, K; Terui, T; Wada, Y | 1 |
1 other study(ies) available for docetaxel anhydrous and Inflammatory Bowel Diseases
Article | Year |
---|---|
A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer.
Topics: Aged; Alleles; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Carboplatin; Codon; DNA; Docetaxel; Drug Therapy, Combination; Female; Follow-Up Studies; Genes, p53; Germ-Line Mutation; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mutation, Missense; Myelodysplastic Syndromes; Ovarian Neoplasms; Ovariectomy; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Skin; Taxoids | 2005 |